Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2002
04/30/2002US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
04/30/2002US6380249 HIV integrase inhibitors
04/30/2002US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus.
04/30/2002US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety
04/30/2002US6380223 For therapy of diseases, such as obesity, diabetes, inflammation
04/30/2002US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages
04/30/2002US6380219 For therapy of arthritis, cancer, tissue ulceration, restenosis, peridontal disease, epidermolysis bullosa, scleritis and other diseases characterized by matrix metalloproteinase activity, sepsis, septic shock
04/30/2002US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal
04/30/2002US6380190 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererof
04/30/2002US6380134 N-pyridyl herbicide compounds
04/30/2002US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation
04/30/2002US6379634 Dissolving in a solvent a material in an initial oxidation state below its maximum oxidation state, wherein the solvent oxidizes it to a higher oxidation state; nuclear fuels
04/30/2002US6379588 Stabilized monomer composition
04/27/2002CA2539147A1 Process for the preparation of non-steroidal glucocorticoid receptor modulators
04/25/2002WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM
04/25/2002WO2002032893A2 Piperidine compounds as anti-allergic
04/25/2002WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance
04/25/2002WO2002032873A1 Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections
04/25/2002WO2002032872A1 Nitrogenous aromatic ring compounds
04/25/2002WO2002032871A2 Compounds and methods for treating multidrug resistance
04/25/2002WO2002032869A2 Substituted heterocyclic compounds for treating multidrug resistance
04/25/2002WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance
04/25/2002WO2002032864A1 Pharmaceutically active sulfanilide derivatives
04/25/2002WO2002032856A2 Insecticidal 1,8-naphthalenedicarboxamides
04/25/2002WO2002032853A1 Process for the preparation of acylphenylalanines
04/25/2002WO2002032845A2 Method of producing carboxylic acid salts
04/25/2002WO2002032389A1 Method of treating stroke
04/25/2002WO2002032377A2 Estrogen receptor modulators
04/25/2002WO2001097810A3 Use of therapeutic benzamide derivatives
04/25/2002WO2001081333A3 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
04/25/2002WO2001056990A3 Pyridine derivates as potentiators of glutamate receptors
04/25/2002US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
04/25/2002US20020049333 Pyridine intermediate compound
04/25/2002US20020049330 Such as 5-(N,N-dibenzyl)aminocarbonyl-2-pyridone; enzyme inhibitors; for treatment of Alzheimer's disease
04/25/2002US20020049288 Metal-ligand complex precursor composition of an amine containing ligand of given formula and group 3,4, or lanthanide metal compound; polymerizing alpha-olefins, higher comonomer content of C4+ olefins
04/25/2002US20020049234 Inhibitors of factor Xa; for example 3-(4-tert-butylbenzoyl)amino-N-(4-methoxyphenyl)-2-thiophenecarboxamide
04/25/2002US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders
04/25/2002US20020049201 Sulfonamide inhibitors of aspartyl protease
04/25/2002US20020049190 Useful in binding nitric oxide; inhibiting tumor growth
04/25/2002US20020048689 Organic compound layer(s) include a compound having a transition metal atom-phosphorus atom bond; blue luminescence
04/25/2002US20020048687 Efficient light emission and excellent heat resistance
04/25/2002US20020047104 Mesomorphic compound, polymeric mesomorphic compound, and electrolyte and secondary battery including same
04/25/2002DE10050723A1 New N-substituted amino acid derivatives for treating thromboembolic diseases e.g. thrombosis, myocardial infarct, arteriosclerosis, inflammation, stroke, angina, restenosis are factor Xa inhibitors
04/25/2002CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system
04/25/2002CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002CA2424729A1 Estrogen receptor modulators
04/25/2002CA2423933A1 Pharmaceutically active sulfanilide derivatives
04/25/2002CA2420994A1 Method of treating stroke
04/24/2002EP1199306A1 Biarylurea derivatives
04/24/2002EP1199305A1 Process for the preparation of 2-aminomethylpyridines
04/24/2002EP1198456A2 Potassium channel openers
04/24/2002EP1198455A1 Process for preparing 1-(6-methylpyridin-3-yl)-2- (4-(methylsulphonyl) phenyl] ethanone
04/24/2002EP1198454A1 Mutilin derivatives and their use as antibacterials
04/24/2002CN1346354A Substituted benzoylpyrazoles as herbicides
04/24/2002CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4
04/24/2002CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia
04/24/2002CN1083435C Conjugated N-fluoropyridinium salt polymer and use thereof
04/24/2002CN1083434C Intermediates for preparation of 2-chloro-5-methypyridine
04/24/2002CN1083433C Herbicidal heterocyclic-substituted pyridines, its preparation and herbicidal composition and use
04/24/2002CN1083432C Process for preparing amine compound and its salt
04/24/2002CN1083419C Pentanoic acid derivatives, its preparation, medicinal materials having same and use thereof
04/23/2002US6376678 Production method of hydrazine derivative
04/23/2002US6376677 Spray drying an aqueous solution of ammonium nicotinate;heating aftertreatment
04/23/2002US6376676 Intermediates in the synthesis of (±)-camptothecin and related compounds and synthesis thereof
04/23/2002US6376665 Antiarthritic agents, antiinflammatory agents
04/23/2002US6376555 Muscle relaxants
04/23/2002US6376548 Enhanced propertied pesticides
04/23/2002US6376538 Antiinflammatory agents; autoimmune diseases
04/23/2002US6376521 A3 adenosine receptor antagonists
04/23/2002US6376518 Anticarcinogenic agents; side effect reduction
04/23/2002US6376515 Benzamides and related inhibitors of factor Xa
04/23/2002US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases
04/23/2002US6376506 Sulfamide-metalloprotease inhibitors
04/23/2002US6376504 Phenethyl-5-bromopyridlythiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DBABO) derivatives exhibiting spermicidal activity
04/23/2002US6376502 Osteoporosis compounds
04/23/2002US6376495 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
04/23/2002US6376494 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
04/23/2002US6376492 Compounds and methods for inhibition of HIV and related viruses
04/23/2002US6376476 Isoprenoid pathway inhibitors for stimulating bone growth
04/23/2002US6376429 Controlling weeds
04/23/2002US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/23/2002CA2282480C Process for the preparation of 10,11-dihydro-5h-dibenzo[a,d]cyclohept-5-enes and derivatives thereof
04/18/2002WO2002030929A1 Novel pleuromutilin derivatives
04/18/2002WO2002030902A1 Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride
04/18/2002WO2002030901A1 Process for making 3-amino-2-chloro-4-methylpyridine
04/18/2002WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
04/18/2002WO2002030881A1 Sulfonylguanidine
04/18/2002WO2002030880A2 N-substituted amino acid derivatives (factor xa inhibitors)
04/18/2002WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
04/18/2002WO2002030866A1 Nitroderivatives as drugs for diseases having an inflammatory basis
04/18/2002WO2002030558A2 A linker and a method of chemical synthesis
04/18/2002WO2002030424A1 Modified prodrug forms of ap/amp
04/18/2002WO2002030405A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
04/18/2002WO2002010228A3 Transformation of polymers to useful chemicals by oxidation
04/18/2002WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/18/2002WO2002003995A3 Treatment of male sexual dysfunction
04/18/2002WO2001087830A3 Substituted thioacetamides
04/18/2002WO2001062709A3 Use of 2-phenylene diamine derivatives for the treatment of infections
04/18/2002US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.